Lawrence J. Hineline Intra Cellular Therapies, Inc. (ITCI) insider trading activity

Lawrence J. Hineline is SVP of Finance, CFO of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Feb 22, 2022, when has been sold 10,443 shares (Common Stock) at a price of $55.36 per share, resulting in proceeds of $578,124. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Lawrence J. Hineline Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2022	SELL Open market or private sale	$578,124 $55.36 p/Share	10,443 Reduced 100.0%	0 Common Stock
Feb 18 2022	BUY Exercise of conversion of derivative security	-	10,443 Added 50.0%	10,443 Common Stock
Jan 10 2022	SELL Open market or private sale	$801,664 $40.82 p/Share	19,639 Reduced 100.0%	0 Common Stock
Jan 08 2022	BUY Exercise of conversion of derivative security	-	19,639 Added 50.0%	19,639 Common Stock
Dec 21 2021	SELL Open market or private sale	$8,121,750 $46.41 p/Share	175,000 Reduced 100.0%	0 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	$2,926,000 $16.72 p/Share	175,000 Added 50.0%	175,000 Common Stock
Feb 19 2021	SELL Open market or private sale	$408,178 $39.09 p/Share	10,442 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	-	10,442 Added 50.0%	10,442 Common Stock
Jan 11 2021	SELL Open market or private sale	$625,667 $31.86 p/Share	19,638 Reduced 100.0%	0 Common Stock
Jan 08 2021	SELL Bona fide gift	-	350 Reduced 100.0%	0 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	-	19,638 Added 50.0%	19,638 Common Stock
Jan 04 2021	SELL Open market or private sale	$492,798 $31.17 p/Share	15,810 Reduced 97.83%	350 Common Stock
Jan 03 2021	BUY Exercise of conversion of derivative security	-	16,160 Added 50.0%	16,160 Common Stock
Nov 11 2020	SELL Open market or private sale	$712,344 $25.41 p/Share	28,034 Reduced 100.0%	0 Common Stock
Nov 11 2020	BUY Exercise of conversion of derivative security	$61,000 $3.05 p/Share	20,000 Added 41.64%	28,034 Common Stock

LJH

Lawrence J. Hineline

SVP of Finance, CFO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Value

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI

Account